# Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

> **NCT02242851** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 5018 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT02242851
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** 5018 (ACTUAL)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242851, "Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02242851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*